2011
DOI: 10.1089/ham.2011.0011
|View full text |Cite
|
Sign up to set email alerts
|

Sildenafil Has Little Influence on Cardiovascular Hemodynamics or 6-km Time Trial Performance in Trained Men and Women at Simulated High Altitude

Abstract: In this group of endurance trained men and women, sildenafil had very little influence on cardiovascular hemodynamics, SaO2, and 6-km time-trial performance at a simulated altitude of ∼3900 m. It appears that a very small percentage of endurance-trained men and women derive meaningful improvements in aerobic performance from sildenafil at a simulated altitude of ∼3900 m.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
26
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 23 publications
(27 citation statements)
references
References 29 publications
1
26
0
Order By: Relevance
“…Although sildenafil has not been included in the World Anti-Doping Agency's list of prohibited substances, it is known that this drug has been used by amateur and high-performance athletes as an ergogenic resource to improve exercise performance [35]. The plau-sibility besides its theory is based on the capacity of sildenafil, during pulmonary hypoxia, to induce pulmonary vasodilation, reducing pulmonary arterial pressure and hypoxic vasoconstriction, which is real factor limiting oxygen uptake, since pulmonary vasoconstriction reduces blood transit time in the lung capillary network, causing lower arterial oxygen saturations [19,20,24,32,38]. However, at normoxic conditions, the benefits of pulmonary vasodilation induced by sildenafil are not clear, since usually oxygen diffusion at the alveolar barrier is not a severe limiting process.…”
Section: Discussionmentioning
confidence: 99%
“…Although sildenafil has not been included in the World Anti-Doping Agency's list of prohibited substances, it is known that this drug has been used by amateur and high-performance athletes as an ergogenic resource to improve exercise performance [35]. The plau-sibility besides its theory is based on the capacity of sildenafil, during pulmonary hypoxia, to induce pulmonary vasodilation, reducing pulmonary arterial pressure and hypoxic vasoconstriction, which is real factor limiting oxygen uptake, since pulmonary vasoconstriction reduces blood transit time in the lung capillary network, causing lower arterial oxygen saturations [19,20,24,32,38]. However, at normoxic conditions, the benefits of pulmonary vasodilation induced by sildenafil are not clear, since usually oxygen diffusion at the alveolar barrier is not a severe limiting process.…”
Section: Discussionmentioning
confidence: 99%
“…However, data are not categorical, both at rest and during exercise. The arterial blood pressure (systolic, diastolic and mean) 1,18,29,31,32 and systolic volume 18,31,32 were almost not affected. Lung function parameters (ventilation, tidal volume, respiratory rate and respiratory exchange ratio) were unaffected by the drug 14,15,18,30 .…”
Section: Sildenafil Effects During Exercise and Hypoxiamentioning
confidence: 90%
“…Lung function parameters (ventilation, tidal volume, respiratory rate and respiratory exchange ratio) were unaffected by the drug 14,15,18,30 . Finally, the exercise values such as W peak 1,14,15,18,29,31,32 or VO 2max 14,29 are not conclusive at all to affirm that sildenafil significantly improves performance during exposure to acute hypoxia, regardless its normobaric or hypobaric nature.…”
Section: Sildenafil Effects During Exercise and Hypoxiamentioning
confidence: 92%
See 1 more Smart Citation
“…There is evidence that sildenafil improves maximal exercise capacity at high altitudes (14,435Y19,028 ft), yet these effects diminish as elevation decreases until no benefit is seen at approximately 13,123 ft or less (9,12,14). Again, while this additional effect may seem attractive as adjunct therapy, the adverse effect profile of PDE-5 inhibitors may limit their practical application.…”
Section: Phosphodiesterase Inhibitorsmentioning
confidence: 99%